Buscar
Mostrando ítems 21-30 de 874
Differential patterns of receptor activator of nuclear factor kappa B ligand/osteoprotegerin expression in human periapical granulomas: Possible association with progressive or stable nature of the lesions
(ELSEVIER SCIENCE INC, 2008)
Receptor activator of nuclear factor kappa B ligand (RANKL) and osteoprotegerin (OPG) are expressed in apical periodontitis, suggesting a role for these molecules during lesion development. However, the profiles of RANKL/OPG ...
Triiodothyronine (T3) does not induce RANKL expression in rat ROS 17/2.8 cells
(Sbem-soc Brasil Endocrinologia & Metabologia, 2014)
NIVELES DE RANKL EN EL LÍQUIDO CREVICULAR GINGIVAL DE PRIMEROS MOLARES EN PACIENTES CON DENTICIÓN MIXTA CLASE I Y CLASE II MOLAR
(Biblioteca Digital wdg.biblioUniversidad de Guadalajara, 1969-12-31)
El descubrimiento del sistema RANK/RANKL/OPG para ajustar la reabsorción ósea ha permitido hacer avances importantes en el estudio de la remodelación ósea. Sin embargo, su papel aún no ha sido dilucidado. Se plantea que ...
Osteoprotegerin/RANKL system imbalance in active polyarticularonset juvenile idiopathic arthritis: a bone damage biomarker?
(TAYLOR & FRANCIS AS, 2008)
Objective: To evaluate the importance of receptor activator of nuclear factor kappa B (RANK)/receptor activator of nuclear factor kappa B ligand (RANKL)/osteoprotegerin (OPG) modulation in active polyarticular juvenile ...
MKK3/6-p38 MAPK signaling is required for IL-1 beta and TNF-alpha-induced RANKL expression in bone marrow stromal cells
(Mary Ann Liebert, Inc., 2006-10-01)
Coupled bone turnover is directed by the expression of receptor-activated NF-kappa B ligand (RANKL) and its decoy receptor, osteoprotegerin (OPG). Proinflammatory cytokines, such as interleukin-1 beta (IL-1 beta) and tumor ...
MKK3/6-p38 MAPK signaling is required for IL-1 beta and TNF-alpha-induced RANKL expression in bone marrow stromal cells
(Mary Ann Liebert, Inc., 2006-10-01)
Coupled bone turnover is directed by the expression of receptor-activated NF-kappa B ligand (RANKL) and its decoy receptor, osteoprotegerin (OPG). Proinflammatory cytokines, such as interleukin-1 beta (IL-1 beta) and tumor ...
RANKL in human periapical granuloma: possible involvement in periapical bone destruction
(BLACKWELL, 2006-05)
OBJECTIVES: The cytokine receptor activator of nuclear factor kappa B-ligand (RANKL) has been involved in both the physiological and pathological regulation of osteoclast life span and bone metabolism. Periapical granuloma ...
Estudo da associação dos genes RANk, RANKL e OPG com a osteopatia diabética
(Universidade Federal do Rio Grande do NorteBrasilUFRNPROGRAMA DE PÓS-GRADUAÇÃO EM CIÊNCIAS DA SAÚDE, 2014-03-31)